trial · primary record
MBS314 for Injection
Multiple Myeloma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 78 |
| Primary completion | 2028-11 |
| Primary endpoint | Phase I ：Percentage of Participants with Adverse Events (AEs) |
| Registry ID | NCT07911748 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:35.876Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07911748
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.